6 results
There is a demand of affordable IPV in the World. Statens Serum Institut (SSI) has developed three reduced dose IPV formulations adsorbed to aluminium hydroxide; 1/3 IPV-Al, 1/5 IPV-Al and 1/10...
The 1998 Technet consultation was held at the WHO Regional Office for Europe, Copenhagen from 16 to 20 March 1998. This consultation gathered a wide range of experts and partners active in...
Studies from low-income countries report positive non-specific effects of early Bacillus Calmette-Guérin (BCG) immunisation on childhood health and survival. Neonatal immunisation with BCG may prime...
The impact of the 13-valent pneumococcal conjugate vaccine (PCV13) at the population level is unclear. We explored PCV13\'s effect in reducing invasive pneumococcal disease (IPD)–related morbidity...
Immunisation information systems (IIS) are valuable tools for monitoring vaccination coverage and for estimating vaccine effectiveness and safety. Since 2009- an advanced IIS has been developed in...